AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Viragen and University of Miami form anticancer project.(Brief Article)
2002 SEP 25 - (NewsRx.com & NewsRx.net) -- Viragen, Inc., (VRA) and the University of Miami's office of technology transfer announced that they have entered into an agreement to develop anticancer technology.
The joint project is designed to develop a novel form of an immune-enhancing drug that has shown promise by inhibiting tumor growth in a broad range of cancers. Additionally, the agreement provides Viragen with an option to acquire an exclusive worldwide license in order to commercialize the technology. United States and foreign patent applications relative to this technology have been filed.
Dr. W. Jarrard Goodwin, director of UM/Sylvester Comprehensive Cancer Center stated, "The University of Miami is very pleased to be working with Viragen to develop a new immune therapy which may be capable of treating many types of cancer. We are committed to participating with Viragen in clinical trials and working with a local company will enhance our community and biotech reputation."
A unique peptide (IEP11) was defined by Dr. Diana Lopez, professor, department of microbiology and immunology and program leader of the Sylvester Cancer Center's tumor immunology and ...
- Viragen International To Trade Under New Symbol.
- Press release article from: PR Newswire March 27, 2002 700+ words
PLANTATION, Fla. -- Viragen, Inc. today announced that its majority-owned subsidiary, Viragen International, Inc. (BULLETIN BOARD...place beginning with today's trading. Viragen International, Inc., formerly named Viragen...
- Viragen Names Karen Jervis Vice President and Managing Director of Viragen...
- Press release article from: PR Newswire Europe October 3, 2005 700+ words
...majority-owned subsidiary, Viragen International, Inc., is...Counter Bulletin Board (VGNI). Viragen's key partners include...UK, Oxford BioMedica Plc, University of Nottingham (U.K...please visit: http://www.Viragen.com . Viragen, Inc. Corporate...
- Viragen to Present at 'BIO-Europe 2004'.
- Press release article from: PR Newswire October 28, 2004 700+ words
...of cancers, Viragen is collaborating...Research UK and the University of Nottingham...Peptide) -- Viragen is collaborating with the University of Miami and...Board (VGNI). Viragen's key partners...Research UK, University of Nottingham...
- Viragen Reports On Stock Market Investigations.
- Press release article from: PR Newswire July 26, 2001 700+ words
...PLANTATION, Fla., July 26 /PRNewswire/ -- Viragen, Inc. (Amex: VRA) today reported...intent to adversely affect the price of Viragen's shares of common stock. The Securities and Exchange Commission has advised Viragen that it is reviewing the complaints filed...
- Viragen and Roslin Institute Announce Extended Agreement; Project Aims to...
- Press release article from: PR Newswire March 8, 2004 700+ words
...Counter Bulletin Board (VGNI). Viragen's key partners and licensors include...Cancer Center, Cancer Research UK, University of Nottingham (U.K.), University...our Web site at: http://www.viragen.com/ Viragen, Inc. Corporate...
- Viragen Obtains Debt Financing.
- Press release article from: PR Newswire April 30, 2003 700+ words
...Counter Bulletin Board (VGNI). Viragen's key partners and licensors include...of Health, Cancer Research UK, University of Nottingham (U.K.), University...please visit our Web site at: www.Viragen.com Viragen, Inc. Corporate Contact...
- Viragen Announces $12 Million Financing Agreement.
- Press release article from: PR Newswire April 1, 2003 700+ words
...Bulletin Board (VGNI). Viragen's key partners and licensors...Health, Cancer Research UK, University of Nottingham (U.K.), University of Miami, America's Blood...and the German Red Cross. Viragen, Inc. Corporate Contacts...
- Viragen's Stockholders Approve to Complete $20 Million Financing.
- Press release article from: PR Newswire June 14, 2004 700+ words
...Counter Bulletin Board (VGNI). Viragen's key partners and licensors include...Cancer Center, Cancer Research UK, University of Nottingham (U.K.), University...please visit: http://www.viragen.com/ Viragen, Inc. Corporate...
Source: HighBeam Research, Viragen and University of Miami form anticancer project.(Brief...